de Jaegere P P T, de Weger A, den Heijer P, Verkroost M, Baan J, de Kroon T, America Y, Brandon Bravo Bruinsma G J
Department of Cardiology, Erasmus University, Rotterdam, The Netherlands.
Department of Cardiothoracic Surgery, University Hospital Leiden, Leiden, The Netherlands.
Neth Heart J. 2020 May;28(5):229-239. doi: 10.1007/s12471-020-01367-4.
The current paper presents a position statement of the Dutch Working Group of Transcatheter Heart Valve Interventions that describes which patients with aortic stenosis should be considered for transcatheter aortic valve implantation and how this treatment proposal/decision should be made. Given the complexity of the disease and the assessment of its severity, in particular in combination with the continuous emergence of new clinical insights and evidence from physiological and randomised clinical studies plus the introduction of novel innovative treatment modalities, the gatekeeper of the treatment proposal/decision and, thus, of qualification for cost reimbursement is the heart team, which consists of dedicated professionals working in specialised centres.
本文展示了荷兰经导管心脏瓣膜介入治疗工作组的一份立场声明,该声明描述了哪些主动脉瓣狭窄患者应被考虑进行经导管主动脉瓣植入术,以及应如何做出这种治疗建议/决定。鉴于该疾病的复杂性及其严重程度评估,特别是结合来自生理学和随机临床研究的新临床见解和证据的不断涌现以及新型创新治疗方式的引入,治疗建议/决定以及费用报销资格的把关者是心脏团队,该团队由在专业中心工作的专业人员组成。